Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tea tree oil versus mupirocin for nasal decolonization in renal dialysis patients
ACTRN12610000874011Phase 2Completed
- Sponsor
- The University of Western Australia
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Tea tree oil and mupirocin in staphylococcal carrier state and catheter infection (2 arms), sponsored by The University of Western Australia. Primary endpoint: Proportion of patients with catheter-related infection within 26 weeks. Started Aug 2010; status: completed.
02
Drugs
Tea tree oilmupirocin
03
Conditions
staphylococcal carrier statecatheter infection
Beyond the preview
Go deeper on ACTRN12610000874011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000874011.